Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023473 (
chronic myeloid leukemia
)
18,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Authors have studied bone marrow CFUc and CLFC of 8 cases affected by idiopathic myelofibrosis, 7 by
chronic granulocytic leukemia
, 6 by polycythemia, and 3 by sideroblastic anemia. The authors studied also C.S.F. activity in peripheral blood of 8 cases. The method of Pike and
Robinson
for in agar culture was utilized. The results indicated a correlation between increase of clusters/colonies fraction, growth of blasts-like clusters, reduction of C.S.F. activity in peripheral blood and transformation in acute leukemia of preleukemic syndromes.
...
PMID:[Evaluation of the proliferative activity of hematopoietic cells in preleukemic syndromes]. 693 4
The sensitivities of hematopoietic colony-forming cells (CFC) to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide (NSC-249992) (m-AMSA) were measured with an in vitro clonogenic assay, a modification of the
Robinson
and Pike human marrow culture system. CFC derived from bone marrow and peripheral blood of normal subjects and patients with
chronic myeloid leukemia
(
CML
) were studied. Sensitivities to m-AMSA did not differ significantly between normal marrow and blood CFC, between normal and
CML
CFC, or between
CML
CFC obtained from patients with leukemias in chronic phase and blast transformation. Drug doses and exposure times producing in vitro hematopoietic inhibition were comparable to clinically employed drug dosages and schedules associated with hematopoietic toxicity.
...
PMID:Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agent. 693 9
Recently, PHA supplemented culture techniques have been introduced for growing colonies of myeloid leukemia cells. To prepare purified leukemic colony forming cell (CFC) suspensions for further studies, a discontinuous albumin density gradient separation method was applied to bone marrow and blood from patients with
chronic myelocytic leukemia
. It was found that the PHA-responding CFC were recovered, just as the leukocyte feeder layer stimulated CFC (
Robinson
CFC), from the light density fractions (1.056, 1.059 and 1.062 g/ml). Density profiles of the precursor cells forming colonies of Ph1 positive cells in the PHA-leukocyte feeder and
Robinson
assays appeared similar. T-lymphocyte progenitor cells, which also proliferate into colonies in the PHA-leukocyte feeder assay, were in majority harvested from the more dense fractions of the gradient. E-rosette tests and chromosome analysis were used to distinguish between leukemic and lymphocytic colonies. The density distributions of the PHA responsive leukemic CFC (Ph1 chromosome positive) and T-lymphocyte CFC (Ph1 negative) partially overlapped and a complete separation of leukemic and lymphocytic CFC was not achieved.
...
PMID:Density profiles and purification of chronic myeloid leukemia cells forming colonies in the PHA-leukocyte feeder assay. 694 37
Investigation of leukemic colony-forming cells (CFC) in PHA-supplemented cultures requires removal of T lymphocyte precursors prior to culture. Using a method of discontinuous density gradient centrifugation with concurrent depletion of E-rosette forming cells, T lymphocytes were effectively separated from light density
CML
bone marrow and blood cell fractions. Consequently, in light density fractions (1.056 and 1.059 g/ml) pure leukemic colony growth was obtained in the PHA-leukocyte feeder (PHA-l.f.) assay. Fraction 1.062 g/ml also yielded pure leukemic colonies in most experiments. Comparison of the density distributions of leukemic PHA-l.f. CFC and
Robinson
CFC revealed that both CFC populations had congruent density profiles in most patients. In others PHA-l.f. CFC were found to be of somewhat higher density than
Robinson
CFC. The most striking divergence was apparent in a patient in blast crisis. The findings suggest that different subsets of precursor cells within the
CML
population proliferate in PHA-l.f. and
Robinson
colony methods. Both colony techniques are thus potentially useful for discriminating subpopulations of colony-forming cells in
chronic myeloid leukemia
.
...
PMID:Studies on chronic myeloid leukemia cell populations with colony-forming abilities in PHA-leukocyte feeder and Robinson assays. 697 34
The interaction of native calf thymus DNA (CT-DNA) with two anthraquinones including quinizarin (1,4-dihydroxy anthraquinone) and danthron (1,8-dihydroxy anthraquinone) in a mixture of 0.04M Brittone-
Robinson
buffer and 50% of ethanol were studied at physiological pH by spectrofluorometric and cyclic voltammetry techniques. The former technique was used to calculate the binding constants of anthraquinones-DNA complexes at different temperatures. Thermodynamic study indicated that the reactions of both anthraquinone-DNA systems are predominantly entropically driven. Furthermore, the binding mechanisms on the reaction of the two anthraquinones with DNA and the effect of ionic strength on the fluorescence property of the system have also been investigated. The results of the experiments indicated that the binding modes of quinizarin and danthron with DNA were evaluated to be groove binding. Moreover, the cytotoxic activity of both compounds against human
chronic myelogenous leukemia
K562 cell line and DNA cleavage were investigated. The results indicated that these compounds slightly cleavage pUC18 plasmid DNA and showed minor antitumor activity against K562 (human
chronic myeloid leukemia
) cell line.
...
PMID:DNA-binding, DNA cleavage and cytotoxicity studies of two anthraquinone derivatives. 2219 18